Results about: diabetes
The group directed by Prof. Guinovart is involved in several projects on glycogen metabolism and its dysfunctions in diabetes and Lafora disease.
Age-related metabolic diseases have increased to epidemic proportions in all industrialized countries.
Researchers discover activators of a potential therapeutic target for the treatment of patients with diabetes and insulin resistance
A team headed by Antonio Zorzano at IRB Barcelona has identified activators of the mitochondrial protein Mitofusin 2 for the treatment of type 2 diabetes.
The protein is a key regulator of many mitochondrial functions, as well as of the cell as a whole.
More than 700 experts on biochemistry and molecular biology take part in the first edition of the FEBS3+ Congress
Professor Antonio Zorzano is the president of the FEBS3+ Congress as well as programme head at IRB Barcelona and the Diabetes and Associated Metabolic Diseases Networking Biomedical Research Centre (CIBERDEM).